BackgroundCheck.run
Search For

Joseph Michael Tuscano, 65452 Trowbridge Ln, Folsom, CA 95630

Known as:
Joseph Michael Dr Tuscano Joseph M Tuscano Joseph Living Tuscano Joseph Tuscano Living Joe M Tuscano
Related to:
Jeremy C Johnson 47

Joseph Tuscano Phones & Addresses

452 Trowbridge Ln, Folsom, CA 95630    916-9836829   

Echo Lake, CA   

Yuba City, CA   

Roseville, CA   

11415 Gold Country Blvd, Gold River, CA 95670   

11784 Long Bar Ct, Rncho Cordova, CA 95670   

Sacramento, CA   

Brick, NJ   

150 Thorndike Way, Folsom, CA 95630   

Social networks

Joseph Michael Tuscano

Linkedin

Work

Company: UC Davis Cancer Center Address: 4501 X St Suite 2, Sacramento, CA 95817 Phones: 916-7345959 (Phone)

Education

School / High School: Keck School Of Medicine Of The Univ Of Southern California 1989
Get Report
Control this profile

Mentions for Joseph Michael Tuscano

Career records & work history

Medicine Doctors

Joseph Tuscano Photo 1

Dr. Joseph M Tuscano, Sacramento CA - MD (Doctor of Medicine)

Address:
UC Davis Cancer Center
4501 X St Suite 2, Sacramento, CA 95817
916-7345959 (Phone)
Hospitals:
UC Davis Cancer Center
4501 X St Suite 2, Sacramento, CA 95817
Education:
Medical Schools
Keck School Of Medicine Of The Univ Of Southern California
Graduated: 1989

Joseph M. Tuscano

Specialties:
Hematology/Oncology
Work:
UC Davis Medical GroupUC Davis Comprehensive Cancer Center
2279 45 St FL 2, Sacramento, CA 95817
916-7345959 (phone) 916-7035265 (fax)
Site
Education:
Medical School
University of Southern California Keck School of Medicine
Graduated: 1989
Procedures:
Bone Marrow Biopsy, Bone Marrow or Stem Cell Transplant, Chemotherapy
Conditions:
Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma, Anemia, Iron Deficiency Anemia, Lung Cancer, Malignant Neoplasm of Esophagus, Malignant Neoplasm of Female Breast, Ovarian Cancer, Prostate Cancer, Rectal, Abdomen, Small Intestines, or Colon Cancer, Testicular Cancer
Languages:
English, Spanish
Description:
Dr. Tuscano graduated from the University of Southern California Keck School of Medicine in 1989. He works in Sacramento, CA and specializes in Hematology/Oncology. Dr. Tuscano is affiliated with UC Davis Medical Center.
Joseph Tuscano Photo 2

Joseph Tuscano, Sacramento CA

Work:
Uc Davis Cancer Center
4501 X St, Sacramento, CA 95817

Joseph Tuscano resumes & CV records

Resumes

Joseph Tuscano Photo 11

Professor

Location:
Folsom, CA
Work:
Uc Davis
Professor

Publications & IP owners

Us Patents

Fermented Wheat Germ Proteins (Fwgp) For The Treatment Of Cancer

US Patent:
2012012, May 17, 2012
Filed:
May 20, 2010
Appl. No.:
13/320898
Inventors:
Joseph Tuscano - Folsom CA, US
Derick Lau - Roseville CA, US
Robert O'Donnell - Sacramento CA, US
Yunpeng Ma - Sichuan, CN
Assignee:
UNITED STATES GOVERNMENT AS THE REPRESENTED BY THE - WASHINGTON DC
REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 38/02
A61K 38/48
A61K 39/395
A61K 38/52
A61P 35/00
C12N 5/09
A61K 38/44
US Classification:
4241741, 514 193, 435375, 514 194, 424 9463, 424 944, 424 945
Abstract:
The present invention provides compositions comprising the component of fermented wheat germ extract (“FWGE”) active in reducing, inhibiting or preventing the proliferation of cancer cells and/or tumors, and methods of making and using such compositions. The active component from FWGE comprises polypeptides having a molecular weight in the range of about 5-100 kiloDaltons (kD), for example, a molecular weight in the range of about 12-50 kD. Exemplary polypeptides from FWGE determined to be active in reducing, inhibiting or preventing the proliferation of cancer cells and/or tumors are listed in Table 1.

Treatment Methods Using Anti-Cd22 Antibodies

US Patent:
2007026, Nov 15, 2007
Filed:
Nov 3, 2006
Appl. No.:
11/592750
Inventors:
Joseph Tuscano - Folsom CA, US
Thomas Tedder - Durham NC, US
Assignee:
The Regents of the University of California - Oakland CA
Duke University - Durham NC
International Classification:
A61K 39/395
US Classification:
424136100, 424133100, 424138100
Abstract:
The invention concerns treatment methods using anti-CD22 monoclonal antibodies with unique physiologic properties. In particular, the invention concerns methods for the treatment of B-cell malignancies by administering an effective amount of a blocking anti-CD22 monoclonal antibody specifically binding to the first two Ig-like domains, or to an epitope within the first two Ig-like domains of native human CD22 (hCD22).

Anti-Cd22 Antigen Binding Molecules To Treat Lung Cancer And Prostate Cancer

US Patent:
2014024, Sep 4, 2014
Filed:
Jun 8, 2012
Appl. No.:
14/123756
Inventors:
Joseph Tuscano - Folsom CA, US
Robert O'Donnell - Sacramento CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 16/30
US Classification:
4241441, 435375, 435366
Abstract:
This invention provides methods for preventing, reducing, delaying or inhibiting the proliferation and/or growth and/or metastasis of lung cancers and prostate cancer that express or overexpress CD22 by contacting the lung cancer cell or prostate cancer cell with an antigen binding molecule that binds to CD22 expressed on the surface of the cancer cell.

Amazon

Joseph Tuscano Photo 13

Targeted Lymphoma Cell Death By Novel Signal Transduction Modifications

Author:
Joseph Tuscano
Publisher:
PN
Binding:
Paperback

Possible Relatives

Heidi Tuscano  Ina T Tuscano  James G Tuscano  Jane B Tuscano  Juan B Tuscano  Robert Tuscano  Robin M Tuscano  Joseph J Johnson  Joseph D Stamps  Joseph N Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.